Date published: 2025-11-21

1-800-457-3801

SCBT Portrait Logo
Seach Input

Slac2-a Inhibitors

Slac2-a Inhibitors belong to a distinct chemical class that has garnered significant attention in the field of molecular biology and cellular physiology. These compounds are characterized by their ability to selectively target and inhibit Slac2-a, a protein of paramount importance in various cellular processes. Slac2-a, also known as Synaptotagmin-like protein 4 (Syt4), is primarily found in synaptic vesicles and plays a crucial role in the regulation of neurotransmitter release. It acts as a calcium sensor and is involved in the exocytosis of neurotransmitters, making it a pivotal player in the intricate machinery of synaptic transmission.

Slac2-a Inhibitors involves their capacity to interfere with the binding of calcium ions to Slac2-a. By doing so, these inhibitors hinder the fusion of synaptic vesicles with the cell membrane, thereby impeding the release of neurotransmitters into the synaptic cleft. This disruption in neurotransmitter release can have profound effects on neuronal communication and synaptic plasticity. Slac2-a Inhibitors have become indispensable tools in neurobiological research, enabling scientists to dissect the intricate processes underlying neurotransmission and synaptic function.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Roscovitine

186692-46-6sc-24002
sc-24002A
1 mg
5 mg
$92.00
$260.00
42
(2)

Roscovitine is a purine analog that inhibits cyclin-dependent kinases (CDKs), which can indirectly affect MLPH function by altering the cell cycle and potentially disrupting intracellular trafficking processes where MLPH is involved.

Taxol

33069-62-4sc-201439D
sc-201439
sc-201439A
sc-201439E
sc-201439B
sc-201439C
1 mg
5 mg
25 mg
100 mg
250 mg
1 g
$40.00
$73.00
$217.00
$242.00
$724.00
$1196.00
39
(2)

Paclitaxel stabilizes microtubules and can disrupt the normal microtubule dynamics necessary for melanosome transport, where MLPH plays a crucial role.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$58.00
$83.00
$140.00
$242.00
38
(2)

Nocodazole is a microtubule-depolymerizing agent that can disrupt the microtubule network, thereby indirectly affecting MLPH-involved melanosome transport.

Colchicine

64-86-8sc-203005
sc-203005A
sc-203005B
sc-203005C
sc-203005D
sc-203005E
1 g
5 g
50 g
100 g
500 g
1 kg
$98.00
$315.00
$2244.00
$4396.00
$17850.00
$34068.00
3
(2)

Colchicine binds to tubulin and inhibits its polymerization into microtubules, indirectly affecting MLPH function by disrupting microtubule-dependent processes.

Monastrol

254753-54-3sc-202710
sc-202710A
1 mg
5 mg
$120.00
$233.00
10
(1)

Monastrol is a kinesin Eg5 inhibitor that disrupts the bipolar spindle formation, indirectly affecting the cellular transport mechanisms where MLPH is involved.

ML-7 hydrochloride

110448-33-4sc-200557
sc-200557A
10 mg
50 mg
$89.00
$262.00
13
(1)

ML-7 is an inhibitor of myosin light chain kinase (MLCK), which can affect cytoskeletal dynamics and influence the intracellular transport pathways involving MLPH.

Gö 6976

136194-77-9sc-221684
500 µg
$223.00
8
(1)

Go6976 is a protein kinase C inhibitor that can modulate signal transduction pathways, indirectly affecting the transport and localization functions of MLPH.

Jasplakinolide

102396-24-7sc-202191
sc-202191A
50 µg
100 µg
$180.00
$299.00
59
(1)

Jasplakinolide is an actin polymerization inducer that can disrupt actin dynamics, indirectly influencing MLPH-associated melanosome transport.

Withaferin A

5119-48-2sc-200381
sc-200381A
sc-200381B
sc-200381C
1 mg
10 mg
100 mg
1 g
$127.00
$572.00
$4090.00
$20104.00
20
(1)

Withaferin A is an inhibitor of vimentin, a component of the cytoskeleton, which can disrupt intermediate filament organization and potentially affect MLPH-related transport processes.

Latrunculin A, Latrunculia magnifica

76343-93-6sc-202691
sc-202691B
100 µg
500 µg
$260.00
$799.00
36
(2)

Latrunculin A is an actin polymerization inhibitor that disrupts actin filaments, indirectly affecting the intracellular transport mechanisms where MLPH operates.